The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 04, 2015
Filed:
Sep. 26, 2013
Applicant:
Reviva Pharmaceuticals, Inc., San Jose, CA (US);
Inventors:
Laxminarayan Bhat, Cupertino, CA (US);
Kouacou Adiey, San Jose, CA (US);
Assignee:
REVIVA PHARMACEUTICALS, INC., Santa Clara, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07C 211/00 (2006.01); A01N 33/02 (2006.01); A61K 31/135 (2006.01); C07C 69/34 (2006.01); C07C 209/48 (2006.01); C07C 209/88 (2006.01); C07C 211/26 (2006.01); C07C 213/06 (2006.01); C07C 213/10 (2006.01); C07C 217/74 (2006.01); C07C 219/06 (2006.01); C07C 231/02 (2006.01); C07C 237/06 (2006.01); C07C 271/20 (2006.01); C07C 229/34 (2006.01); C07C 69/96 (2006.01); C07C 237/22 (2006.01);
U.S. Cl.
CPC ...
C07C 69/34 (2013.01); C07C 69/96 (2013.01); C07C 209/48 (2013.01); C07C 209/88 (2013.01); C07C 211/26 (2013.01); C07C 213/06 (2013.01); C07C 213/10 (2013.01); C07C 217/74 (2013.01); C07C 219/06 (2013.01); C07C 229/34 (2013.01); C07C 231/02 (2013.01); C07C 237/06 (2013.01); C07C 237/22 (2013.01); C07C 271/20 (2013.01); C07C 2101/04 (2013.01);
Abstract
The present invention provides novel cycloalkylmethylamine derivatives, and methods of preparing cycloalkylmethylamine derivatives. The present invention also provides methods of using cycloalkylmethylamine derivatives and compositions of cycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.